The Story Behind the Headlines When a massive merger makes the news — like Kimberly-Clark’s recent $48.7 billion acquisition of Kenvue, the maker of Tylenol, Listerine, and Band-Aid — investors rush to interpret what it means.The headlines focused on the numbers: Kimberly-Clark’s shares fell 15% before the market opened, while Kenvue’s soared over 20%. But […]